Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bobbie Rimel"'
Autor:
Bobbie Rimel, Tirza Areli Calderón Boyle, Sara Burns, Jonathan Lim, John Hartman, Linda Kalilani, Jeanne M. Schilder, Jean A. Hurteau, Amanda Golembesky
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 465-475 (2024)
Abstract Introduction Clinical trials have demonstrated prolonged survival associated with niraparib first-line maintenance (1LM) therapy, compared with placebo, for patients with ovarian cancer (OC). However, data are limited on real-world 1LM nirap
Externí odkaz:
https://doaj.org/article/be7e5d732cdc4346b5c2c634f5e5b807
Autor:
Nicole Gull, Michell Jones, Pei-Chen Peng, Simon Coetzee, Tiago Silva, Jasmine Plummer, Alberto Reyes, Brian Davis, Stephanie Chen, Kate Lawrenson, Jenny Lester, Christine Walsh, Bobbie Rimel, Andrew Li, Ilana Cass, Yonatan Berg, John Paul Govindavari, Joanna Rutgers, Benjamin Berman, Beth Karlan, Simon Gayther
Background Little is known about the role of global DNA methylation in recurrence and chemoresistance of high grade serous ovarian cancer (HGSOC). Methods We performed whole genome bisulfite sequencing and transcriptome sequencing in 62 primary and r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08266e125eddfb39d538e63d7c2449cf
https://doi.org/10.21203/rs.3.rs-1214611/v1
https://doi.org/10.21203/rs.3.rs-1214611/v1
Autor:
Nolan Kinne, Christopher Mayer, Kristin Taylor, Michael Manuel, Bobbie Rimel, Kenneth Kim, Andrew Li
Publikováno v:
Gynecologic Oncology. 166:S196-S197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f93353384bb7c8423e22c9094408418b
https://doi.org/10.1016/s0090-8258(22)01607-9
https://doi.org/10.1016/s0090-8258(22)01607-9
Autor:
Joshua Brand, Marcela Haro, Forough Abbasi, Xianzhi Lin, Matthew Siedhoff, Andrew Li, Bobbie Rimel, Fabiola Medeiros, Kate Lawrenson, Huy Dinh
Publikováno v:
The Journal of Immunology. 208:179.03-179.03
The 5-year survival rate of high grade serous ovarian cancer (HGSOC) has remained below 40% for decades. This rises significantly to 90% when detected early. Increasing evidence suggests that HGSOC tumors originate in the fallopian tube (FT). However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f59a4afb58a1a1e614be1054fbaf87ee
https://doi.org/10.4049/jimmunol.208.supp.179.03
https://doi.org/10.4049/jimmunol.208.supp.179.03